Business Description
Sensei Biotherapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US81728A1088
Share Class Description:
FRA:407: Ordinary SharesDescription
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.36 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.18 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -23.7 | |||||
| 3-Year EPS without NRI Growth Rate | -20.6 | |||||
| 3-Year FCF Growth Rate | -21.6 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 7.78 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.9 | |||||
| 9-Day RSI | 42.15 | |||||
| 14-Day RSI | 42.7 | |||||
| 6-1 Month Momentum % | -42.56 | |||||
| 12-1 Month Momentum % | -21.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | |||||
| Quick Ratio | 10.9 | |||||
| Cash Ratio | 10.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 5.4 | |||||
| Shareholder Yield % | 15.47 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -45.54 | |||||
| ROA % | -39.87 | |||||
| ROIC % | -308.27 | |||||
| 3-Year ROIIC % | -209.18 | |||||
| ROC (Joel Greenblatt) % | -418.14 | |||||
| ROCE % | -42.84 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.24 | |||||
| Price-to-Tangible-Book | 0.24 | |||||
| EV-to-EBIT | 1.17 | |||||
| EV-to-EBITDA | 1.23 | |||||
| EV-to-FCF | 1.42 | |||||
| Price-to-Net-Current-Asset-Value | 0.27 | |||||
| Price-to-Net-Cash | 0.28 | |||||
| Earnings Yield (Greenblatt) % | 85.47 | |||||
| FCF Yield % | -193.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sensei Biotherapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.091 | ||
| Beta | 0.21 | ||
| Volatility % | 74.04 | ||
| 14-Day RSI | 42.7 | ||
| 14-Day ATR (€) | 0.028213 | ||
| 20-Day SMA (€) | 0.43305 | ||
| 12-1 Month Momentum % | -21.07 | ||
| 52-Week Range (€) | 0.391 - 1.69 | ||
| Shares Outstanding (Mil) | 25.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sensei Biotherapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sensei Biotherapeutics Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sensei Biotherapeutics Inc Frequently Asked Questions
What is Sensei Biotherapeutics Inc(FRA:407)'s stock price today?
The current price of FRA:407 is €0.40. The 52 week high of FRA:407 is €1.69 and 52 week low is €0.39.
When is next earnings date of Sensei Biotherapeutics Inc(FRA:407)?
The next earnings date of Sensei Biotherapeutics Inc(FRA:407) is 2024-11-07 Est..
Does Sensei Biotherapeutics Inc(FRA:407) pay dividends? If so, how much?
Sensei Biotherapeutics Inc(FRA:407) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers